Knobbe Martens Delivers Federal Circuit Win for Lupin in Hatch-Waxman Dispute Involving Kidney Disease Drug
WASHINGTON, D.C., May 21, 2026 – A team from Knobbe Martens secured a substantial appellate victory on behalf of Lupin Ltd., ensuring patients a cost-effective option for treating life-threatening kidney...
Litigation Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
Trademark & Brand Protection Update | May 2026
Taylor Swift, Trademarks, and the Pursuit of a Federal Right of Publicity Dillon A. Koch & Jonathan Menkes Taylor Swift’s recent trademark filings for her voice and likeness point to a...